Filing Flows › Companies › National Healthcare › Timeline
National Healthcare stock timeline
A year of the price with every insider trade, planned sale, earnings report and material 8-K marked
252 sessions+69.4% to $208.85
National Healthcare (NHC) stock rose 69% over the last 252 sessions, to $208.85. On the way it reported 0 quarters, its insiders filed 21 open-market trades and 1 Form 144 notice of planned sales, and the company filed 6 material 8-Ks. Each is marked on the price and listed with what the stock did next.
Each mark, and what followed
| Date | Kind | What | Next session | 5 sessions | 21 sessions |
|---|---|---|---|---|---|
| Sep 22, 2026 | Insider sale | Dodson Vicki L sold $1.1M | −0.2% (−0.2% vs SPY) | +1.2% (+2.2% vs SPY) | +10.8% (+11.3% vs SPY) |
| Sep 11, 2026 | Insider sale | Kidd Brian F sold $1.5M | −0.2% (−1.0% vs SPY) | 0.0% (−0.7% vs SPY) | +1.3% (−1.7% vs SPY) |
| Sep 10, 2026 | Form 144 | Form 144: Josh A McCreary plans to sell $601K | −1.0% (−0.4% vs SPY) | −0.8% (+0.3% vs SPY) | −0.6% (−2.4% vs SPY) |
| Sep 10, 2026 | Insider sale | McCreary Josh A sold $610K | −1.0% (−0.4% vs SPY) | −0.8% (+0.3% vs SPY) | −0.6% (−2.4% vs SPY) |
| Aug 28, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $222K | +0.2% (+0.4% vs SPY) | −0.3% (−0.5% vs SPY) | +1.7% (+2.1% vs SPY) |
| Aug 25, 2026 | Insider sale | Gifford David R. sold $401K | −1.6% (−1.9% vs SPY) | −5.3% (−5.8% vs SPY) | −1.6% (−2.4% vs SPY) |
| Aug 25, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $227K | −1.6% (−1.9% vs SPY) | −5.3% (−5.8% vs SPY) | −1.6% (−2.4% vs SPY) |
| Aug 20, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $237K | +1.1% (+2.0% vs SPY) | −3.9% (−3.5% vs SPY) | −5.2% (−4.5% vs SPY) |
| Aug 19, 2026 | Insider sale | Flatt Stephen Fowler sold $356K | −0.1% (−0.3% vs SPY) | −4.1% (−3.9% vs SPY) | −4.1% (−3.4% vs SPY) |
| Aug 19, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $237K | −0.1% (−0.3% vs SPY) | −4.1% (−3.9% vs SPY) | −4.1% (−3.4% vs SPY) |
| Aug 17, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $226K | +2.0% (+2.5% vs SPY) | +4.3% (+5.6% vs SPY) | +1.3% (+3.8% vs SPY) |
| Aug 14, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $222K | +1.7% (+1.9% vs SPY) | +7.4% (+9.4% vs SPY) | +3.5% (+5.7% vs SPY) |
| Aug 12, 2026 | Insider sale | Flatt Ben Anderson Sr. sold $221K | +2.3% (+2.0% vs SPY) | +7.7% (+8.1% vs SPY) | +3.7% (+5.4% vs SPY) |
| Jul 1, 2026 | 8-K | Material definitive agreement | +2.7% (+2.8% vs SPY) | +0.7% (−0.1% vs SPY) | +6.1% (+5.9% vs SPY) |
| Jun 22, 2026 | Insider sale | Hassan Emil E sold $1.2M | −0.1% (+0.3% vs SPY) | +2.5% (+4.9% vs SPY) | +10.4% (+10.2% vs SPY) |
| Jun 16, 2026 | Insider sale | Hassan Emil E sold $313K | −1.9% (−1.3% vs SPY) | +2.0% (+4.6% vs SPY) | +14.2% (+14.5% vs SPY) |
| Jun 1, 2026 | Insider buy | Piercey Lisa bought $175K | −2.8% (−3.0% vs SPY) | +4.1% (+6.6% vs SPY) | +14.0% (+15.0% vs SPY) |
| May 27, 2026 | 8-K | Material definitive agreement | −3.8% (−4.4% vs SPY) | −2.9% (−3.4% vs SPY) | +7.3% (+10.0% vs SPY) |
| May 21, 2026 | Insider sale | Laroche Richard F Jr. sold $1.5M | −1.8% (−2.0% vs SPY) | −7.6% (−9.4% vs SPY) | +1.0% (+0.3% vs SPY) |
| May 19, 2026 | Insider sale | Shelly Timothy J. sold $365K | −0.2% (+0.5% vs SPY) | −3.3% (−4.9% vs SPY) | −2.7% (−3.0% vs SPY) |
| May 15, 2026 | 8-K | Material definitive agreement | +1.4% (+1.4% vs SPY) | +1.2% (+0.3% vs SPY) | −0.9% (−2.4% vs SPY) |
| Apr 22, 2026 | 8-K | Material definitive agreement | −1.8% (−1.4% vs SPY) | +0.8% (+0.8% vs SPY) | +12.1% (+7.8% vs SPY) |
| Feb 17, 2026 | 8-K | Directors and officers: departures, appointments, pay | −2.8% (−3.0% vs SPY) | −7.7% (−7.8% vs SPY) | −4.2% (−2.6% vs SPY) |
| Dec 17, 2025 | Insider sale | Shelly Timothy J. sold $342K | +1.1% (+2.2% vs SPY) | +0.2% (−1.4% vs SPY) | −0.8% (−3.0% vs SPY) |
| Nov 25, 2025 | Insider sale | Hassan Emil E sold $1.0M | +4.3% (+3.4% vs SPY) | +3.8% (+1.9% vs SPY) | +4.8% (+1.3% vs SPY) |
| Nov 21, 2025 | Insider sale | Flatt Stephen Fowler sold $130K | +2.4% (+1.4% vs SPY) | +6.8% (+2.2% vs SPY) | +11.0% (+5.9% vs SPY) |
| Nov 12, 2025 | 8-K | Directors and officers: departures, appointments, pay | −2.1% (−0.4% vs SPY) | −2.5% (+0.6% vs SPY) | +6.9% (+7.2% vs SPY) |
| Nov 12, 2025 | Insider sale | Hassan Emil E sold $732K | −2.2% (−2.3% vs SPY) | −5.7% (−2.3% vs SPY) | +4.1% (+3.2% vs SPY) |
Insiders’ record here
In the year on the chart, National Healthcare's insiders reported 1 open-market buy ($175K) and 20 sales ($11.2M). Of the 9 old enough to score, 1 were followed by the stock doing what the trade implied over the next 63 sessions (beating SPY after a buy, lagging it after a sale); the median excess return after a buy was +19.6% and after a sale +16.9%.
Across the whole universe (19,782 scored trades), insider buys beat the market 46% of the time and sales were followed by a lagging stock 61% of the time; buys of $1M or more 39%. Every pattern →
What this kind of 8-K usually did
| Item | 8-Ks | Next session, median | Up next session | 21 sessions, median | Typical size |
|---|---|---|---|---|---|
| 5.02 Directors and officers: departures, appointments, pay | 39,174 | −0.1% | 48% | +0.7% | ±1.4% |
| 1.01 Material definitive agreement | 23,525 | 0.0% | 51% | +1.0% | ±1.4% |
| 1.02 Termination of a material agreement | 2,368 | 0.0% | 51% | +1.1% | ±1.5% |
| 2.03 New debt or off-balance-sheet obligation | 13,268 | 0.0% | 50% | +1.2% | ±1.3% |
| 2.01 Completed acquisition or disposition | 2,671 | +0.1% | 52% | +1.2% | ±1.6% |
Across every company in the move-odds universe, measured from the close before the filing. Every 8-K item ranked →
National Healthcare: every quarter → Live insider trades →
Prices are daily closes; filings and trades are as filed with the SEC (Form 4 within two business days of the trade, 8-K within four of the event). Moves after a mark are the stock's close-to-close change and the same for SPY; they describe the record, not what the next one will do. Not investment advice.